Wells Fargo & Company »

Neumora Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.1k 5.0k 1.82
2025-06-30 $5.0k 6.8k 0.73
2025-03-31 $46k 46k 1.00
2024-12-31 $749k 71k 10.60
2024-09-30 $759k 58k 13.21
2024-06-30 $575k 59k 9.83
2024-03-31 $481k 35k 13.75
2023-12-31 $466k 27k 17.05